KELSEY DE VILLIERS: Open Payments
NPI 1669222865 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $73 |
| ABBVIE INC. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Amgen Inc. | 3 | $44 |
| Exact Sciences Corporation | 2 | $36 |
| Nalu Medical, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Ozempic, QULIPTA, REPATHA, Cologuard Collection Kit, AIRSUPRA, Nalu Neurostimulation System, Veozah, NURTEC ODT.
Industry payments across AZ — which companies pay providers there.
